West Pharmaceutical Services (WST) Leases (2016 - 2025)
Historic Leases for West Pharmaceutical Services (WST) over the last 13 years, with Q3 2025 value amounting to $97.8 million.
- West Pharmaceutical Services' Leases fell 944.44% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.8 million, marking a year-over-year decrease of 944.44%. This contributed to the annual value of $104.5 million for FY2024, which is 534.27% up from last year.
- Latest data reveals that West Pharmaceutical Services reported Leases of $97.8 million as of Q3 2025, which was down 944.44% from $104.4 million recorded in Q2 2025.
- In the past 5 years, West Pharmaceutical Services' Leases ranged from a high of $110.3 million in Q2 2024 and a low of $58.5 million during Q3 2021
- Moreover, its 5-year median value for Leases was $97.8 million (2025), whereas its average is $90.5 million.
- Per our database at Business Quant, West Pharmaceutical Services' Leases crashed by 1333.33% in 2021 and then soared by 5064.94% in 2022.
- Quarter analysis of 5 years shows West Pharmaceutical Services' Leases stood at $69.3 million in 2021, then surged by 50.65% to $104.4 million in 2022, then fell by 4.98% to $99.2 million in 2023, then grew by 5.34% to $104.5 million in 2024, then fell by 6.41% to $97.8 million in 2025.
- Its Leases was $97.8 million in Q3 2025, compared to $104.4 million in Q2 2025 and $103.4 million in Q1 2025.